Emphysema.app

Curated by Signal

Provider of assessment tool for emphysema patients

Overview

Emphysema.App provides an assessment tool to detect the severity of emphysema in COPD patients. The tool calculates patient health data and gives insights as ESI (Emphysema Severity Index). The mobile-based platform acts as a spirometer detecting the real-time changes in the patient's health. The Saas based platform helps practitioners to diagnose their patients by giving automated reports and calculations for better treatment decisions.

Key facts

Founded: 2018
Headquarters: Florence, Italy
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

PlanetFarma
Online platform for the purchase of supplements and medicines
Health TechnologyBusalla, Italy
BioT
Provider of online courses and training platform for life sciences
Health TechnologyRoma, Italy
Bioimis
Digital telehealth solution for healthcare professionals
Health TechnologyBassano del Grappa, Italy

About Emphysema.app

What does Emphysema.app do?

Emphysema.App provides an assessment tool to detect the severity of emphysema in COPD patients.

Where is Emphysema.app headquartered?

Emphysema.app is headquartered in Florence, Italy.

When was Emphysema.app founded?

Emphysema.app was founded in 2018.

Which sector is Emphysema.app in?

Emphysema.app operates in Health Technology.

Who are Emphysema.app's competitors?

Companies similar to Emphysema.app include PlanetFarma, BioT, and Bioimis.